Veterinary Contract Manufacturing & Research Market

The report "Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031", is projected to reach USD 9.24 billion by 2031 from USD 6.38 billion in 2026, at a CAGR of 7.7% during the forecast period.

Browse 585 market data Tables and 71 Figures spread through 498 Pages and in-depth TOC on "Veterinary Contract Manufacturing & Research Market by Service (Discovery, API Development, Regulatory Affairs, Consulting, Packaging & Labeling), Product (API, Fill-Finish, Medical Devices), Animal Type (Companion, Livestock) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/veterinary-contract-manufacturing-and-research-market-123382191.html

The veterinary contract manufacturing & research market is witnessing strong growth driven by demographic, economic, and technological factors. Rising demand for efficient and cost-effective drug development, testing, and manufacturing solutions is accelerating outsourcing across vaccines, biologics, and small-molecule therapeutics. Animal health companies, research institutions, and veterinary diagnostic laboratories are increasingly partnering with CDMOs and CROs to enhance R&D productivity, improve study quality, and shorten time-to-market. Technological advancements—such as AI-enabled predictive modeling, digitalized clinical trial management, automation in bioprocessing, and advanced analytical platforms—are transforming workflows and enabling more precise, data-driven decision-making. Additionally, the growing use of scalable single-use systems, improved quality management tools, and cloud-based data platforms is enhancing efficiency, flexibility, and regulatory compliance across the veterinary outsourcing ecosystem.

By product type, the medicines segment accounted for the largest market share in 2024.

In the veterinary contract manufacturing & research market, the medicines segment accounted for the largest market share in 2024. This dominance is primarily due to their core focus on animal health R&D and their account for the highest volume of outsourced development and manufacturing activities. The growing need for new therapeutics, such as antibiotics, pain management drugs, parasiticides, and treatments for chronic and infectious diseases, drives the continuous development of product pipelines among animal health companies. As regulations become more stringent and formulations grow more complex, companies increasingly rely on CDMOs and CROs for expertise in formulation, scale-up, analytical testing, and GMP-compliant production. This consistent and high demand for veterinary pharmaceuticals makes medicines the dominant product category in the market.

By end user, the startups & veterinary biotech firms segment is projected to grow at the highest CAGR during the forecast period.

The startups & veterinary biotech firms segment is projected to grow at the highest CAGR during the forecast period because they rely heavily on outsourcing to access advanced technologies, specialized expertise, and GMP-compliant facilities that they lack in-house. Their focus on innovative platforms—such as novel biologics, gene-based therapies, advanced formulations, and digital health tools—drives high demand for CDMO and CRO support across early-stage R&D, scale-up, and clinical studies. With strong investor interest and a surge in new pet health and livestock innovation ventures, these companies are rapidly increasing their outsourcing needs, fueling segment growth.

By region, North America held the largest market share in 2024.

In 2024, North America accounted for the largest share of the veterinary contract manufacturing & research market due to its strong presence of leading animal health companies, advanced R&D infrastructure, and high investment in veterinary therapeutics and biologics. The region benefits from robust regulatory frameworks, well-established GMP-compliant manufacturing capabilities, and widespread adoption of innovative technologies. High pet healthcare spending, significant owner awareness, and extensive presence of specialized CDMOs and CROs further reinforce North America’s dominant position in the global market.

Key Market Players

The prominent players in the veterinary contract manufacturing & research market are Fareva (France), Vetio (US), Aenova Group (Germany), TriRx Pharmaceutical Services (US), Argenta Holdco Limited (UK), Labcorp (US), Eurofins Scientific (Luxembourg), Charles River Laboratories (US), knoell Germany GmbH (Germany), and Evotec (Germany) , among others.

Don’t miss out on business opportunities in Veterinary Contract Manufacturing & Research Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/